Search Results for: MGUS
Lesson 3: Diagnostic Testing
A diagnosis of Pre-Meloma is relatively rare mainly because there are few symptoms and pre-mm is difficult to assess. The good news is that diagnostic testing is the best and only way of keeping an
Continue readingSmoldering to Myeloma- Imaging too?
While trying to predict the risk of smoldering multiple myeloma (SMM) from becoming full multiple myeloma (MM) is a worthwhile endeavor, no method of predicting SMM to full MM is 100% accurate. The study
Continue readingReduce Inflammation to Reduce MM Risk?
Evidence-Based, Non-Toxic, Non-Conventional Cancer Therapies Will Eliminate Inflammation- If you’ve been diagnosed with pre-myeloma- SBP, MGUS or SMM- your blood disorder is not your worry. Your
Continue readingSMM or MM- What’s the difference?
Multiple myeloma is defined as smoldering (asymptomatic) or active (symptomatic). The NCCN criteria for smoldering multiple myeloma are as follows The presence of any of the CRAB criteria or any of
Continue readingMultiple Myeloma Treatment- Very Slow Responder…
The challenge for those newly diagnosed Multiple Myeloma patients that achieve remission is that the toxicity of those therapies can cause life-threatening side effects to the patient’s blood, bones,
Continue readingFamilial Multiple Myeloma Survivor Increases Your Risk of MM
“The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies (MM).” Second only to “Why did I get
Continue readingWait for Pre-Myeloma to Progress or Try Non-Conventional Therapies?
Now we have to wonder how long the lesion (pre-myeloma) will sit there. We can’t pretend they’re not there, but we don’t know what they mean. A single plasmacytoma (SBP), monoclonal gammopathy of
Continue readingPre-Myeloma- Pesticides, Virus’, Environment?
“Among study participants older than 50 years, 38 were found to have MGUS, (pre-myeloma) yielding a prevalence of 6.8% What caused my pre-myeloma (MGUS, SMM, MM) is the first question many of us
Continue readingSolitary Plasmacytoma- In Bone, Outside of Bone?
Solitary plasmacytomas most frequently occur in bone (plasmacytoma of bone), but can also be found outside bone in soft tissues (extramedullary plasmacytoma) . The diagnosis and management of SPB will
Continue readingSMM Progression- M-spike and FLC are key-
Several prediction models for SMM progression to MM have been proposed and are typically based on a combination of biomarkers at diagnosis, such as level of MP, BMPCs, and FLCr. Hi David- I have been
Continue readingSlow/Stop SMM’s March Toward Full-Blown Multiple Myeloma
“Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM Hi David-I contacted you a couple months
Continue readingSmoldering Myeloma, TTP, Risk, Non-toxic Treatment
“…though they said their model was not able to accurately discriminate between patients with one or two risk factors during the first 2 to 3 years…” Let’s be clear. A risk
Continue reading